InMed Pharmaceuticals (MWG) Financial Statements

1 Followers

InMed Pharmaceuticals Financial Overview

InMed Pharmaceuticals's market cap is currently €3.79M. The company's EPS TTM is €-1022.64; its P/E ratio is >-0.01; InMed Pharmaceuticals is scheduled to report earnings on September 9, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Income Statement
Total Revenue	$ 3.18B	$ 4.94M	$ 4.60M	$ 4.14M	$ 1.09M
Gross Profit	$ 709.84M	$ 1.71M	$ 1.10M	$ 1.40M	$ 543.55K
Operating Income	$ -1.19B	$ -7.92M	$ -8.13M	$ -8.38M	$ -13.79M
EBITDA	$ -1.19B	$ -7.26M	$ -7.06M	$ -7.34M	$ -18.09M
Net Income	$ -1.19B	$ -8.16M	$ -7.68M	$ -7.95M	$ -18.60M
Balance Sheet
Cash & Short-Term Investments	$ 2.23B	$ 15.09M	$ 8.99M	$ 11.81M	$ 8.01M
Total Assets	$ 3.03B	$ 21.23M	$ 16.17M	$ 18.69M	$ 16.46M
Total Debt	$ 0.00	$ 1.01M	$ 1.32M	$ 518.92K	$ 1.02M
Net Debt	$ -2.19B	$ -14.08M	$ -7.67M	$ -11.29M	$ -6.93M
Total Liabilities	$ 1.96B	$ 2.92M	$ 3.58M	$ 2.67M	$ 4.78M
Stockholders' Equity	$ 1.08B	$ 18.30M	$ 12.59M	$ 16.02M	$ 11.69M
Cash Flow
Free Cash Flow	$ -8.64B	$ -7.77M	$ -7.00M	$ -7.45M	$ -15.62M
Operating Cash Flow	$ -8.64B	$ -7.77M	$ -6.99M	$ -7.28M	$ -15.58M
Investing Cash Flow	$ 0.00	$ 0.00	$ -9.29K	$ -661.80K	$ -673.00K
Financing Cash Flow	$ 94.50M	$ 12.27M	$ 4.65M	$ 10.68M	$ 15.07M

InMed Pharmaceuticals Earnings and Revenue History

Income Statement >

InMed Pharmaceuticals Debt to Assets

Balance Sheet >

InMed Pharmaceuticals Cash Flow

Cash Flow >

InMed Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >